IBIS Capital’s latest industry research report includes an 80-page deep dive into the pharmaceutical industry’s move towards digitisation and the innovative digital health businesses enabling the industry’s evolution. The report analyses 1,300+ digital health companies across 6 segments and includes data across 3,500+ transactions and 30+ IPOs. We discuss M&A and fundraising trends, business models, public market dynamics and investment outlook.

Download the report for free here.